Close

Rating History for Halozyme Therapeutics (HALO) by Wells Fargo

More Stocks Rated by Wells Fargo | Latest Ratings for HALO
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
1/18/2024 Mohit Bansal Maintain Overweight
(N/A)		 48.00
(52.00)		  
 		   Details